![Jeffrey Albers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Albers
Président chez
SPYRE THERAPEUTICS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Actuellement, Jeffrey W. Albers occupe le poste de président, chef de la direction et directeur de Blueprint Medicines Corp. M. Albers est également membre du conseil d'administration de Magenta Therapeutics, Inc. et Kymera Therapeutics, Inc. et directeur de la division Nouvelle-Angleterre de l'American Cancer Society, Inc. Auparavant, il a occupé le poste de vice-président de l'activité hématologie et oncologie aux États-Unis chez Sanofi et de vice-président de l'unité commerciale hématologie et oncologie aux États-Unis chez Genzyme Corp. (une filiale de Sanofi), avocat chez Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC et président chez Algeta ASA. M. Albers a obtenu un diplôme de premier cycle à l'université d'Indiana et un diplôme d'études supérieures et un MBA à l'université de Georgetown.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/05/2026 | 27 360 ( 0,03% ) | 2 M $ | 31/05/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Jeffrey Albers
| Sociétés | Poste | Début |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/07/2020 |
| SPYRE THERAPEUTICS, INC. | Président | - |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Corporate Officer/Principal | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01/01/2023 |
MOMA Therapeutics, Inc.
 MOMA Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for regenerative medicine employing injectable gel-based scaffolds | Président | 08/02/2023 |
Pheon Therapeutics Ltd.
 Pheon Therapeutics Ltd. BiotechnologyHealth Technology Develops antibody drug to treat cancers | Président | - |
Anciens postes connus de Jeffrey Albers
| Sociétés | Poste | Fin |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Directeur Général | 04/04/2022 |
| MAGENTA THERAPEUTICS | Directeur/Membre du Conseil | 12/09/2023 |
| ALGETA ASA | President | 30/04/2014 |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jeffrey Albers
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Commercial Services |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
MOMA Therapeutics, Inc.
MOMA Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for regenerative medicine employing injectable gel-based scaffolds | Health Technology |
Pheon Therapeutics Ltd.
Pheon Therapeutics Ltd. BiotechnologyHealth Technology Develops antibody drug to treat cancers | Health Technology |
